Hidden in plain sight
Defeating Ocular Melanoma begins here.Just as you can develop melanoma on your skin, you can also develop it inside your eye.
AOMA is working with clinicians and patients in an effort to defeat ocular melanoma.
What is AOMA?
The Australasian Ocular Melanoma Alliance (AOMA) is a group of medical, para-medical, nursing and consumer representatives aiming to further care and treatment of patients with ocular melanoma across Australia and the world.
What is Ocular Melanoma?
Melanoma is a form of cancer that forms in melanocytes, the cells in the body that produce pigment. Melanoma that develops in parts of the eye are called ocular melanoma. There are 2 primary types:
Upcoming Events
Australasia’s premier ocular melanoma cross-disciplinary meeting
Building on the previously highly successful Australasian Ocular Melanoma Alliance (AOMA) summits, the 4th AOMA Summit will bring together healthcare professionals, researchers and consumers in ocular melanoma to share the latest research and facilitate national and international collaborations for this rare, debilitating and often devastating cancer.
This free virtual event will include a scientific program and presentations focused on consumer and advocate involvement.
The diverse program will cover laboratory and translational research, clinical trials and registries, diagnosis and clinical management, updates on current and future treatment options, as well as consumer and clinician discussion panels.
Newsfeed
Our protocol paper for the IMAGE trial investigating early detection using #melanoma surveillance photography is now published in @BioMedCentral.
https://t.co/kAv6q8DVa2
@DrVictoriaMar @AnneECust @hpsoyer @MonikaJanda @ByarsGabrielle @RMahumud @PabloFP_Syd
Registrations now open! Australasian Ocular Melanoma Alliance (AOMA) Virtual Summit, 24 June. This free, all-day online event will feature international & Australian ocular melanoma experts + consumer sessions.
Register: https://t.co/zmanVoBqfI
@AnthonyMJoshua @IrisMelanoma https://t.co/cHYlg1EIgb
Terrific discussion by @AnthonyMJoshua on tebentafusb for uveal melanoma: to be or not tebe? #AMC2023 https://t.co/qWfNxH5fNM
Research
Communications
Support
